SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: Steve Fancy who wrote (5660)11/10/1998 1:44:00 PM
From: sam  Read Replies (1) | Respond to of 6136
 
As Henry posted, David Molowa (of Bear Stearns) claimed that AGPH had "put itself up for sale." I doubt the BS traders were caught unaware when he did so. But I could be wrong. I often am wrong when trying to understand this stock. The reason I asked about MSDW is because I haven't heard much from Linde since he downgraded AGPH. This seems like the "perfect" time for an upgrade, don't you think? ;) BTW, MS stopped buying after I posted my last message. Now both buying and selling is coming from institutions.



To: Steve Fancy who wrote (5660)11/10/1998 2:33:00 PM
From: billkirn  Read Replies (1) | Respond to of 6136
 
Steve: I still think the company is worth around 75 per share on a buy out basis. I don't think they can get it, and I don't think they will sell at less.
Bill